Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
DOWNLOAD WHITEPAPER

AtreMorine: A Biotechnological / Nutraceutical product for Parkinson’s

AtreMorine is a novel biopharmaceutical compound obtained by means of nondenaturing biotechnological procedures from the structural components of the Vicia faba L plant, for the prevention and treatment of Parkinson´s disease (PD) and related disorders.

E-PodoFavalin-15999 extract is the structural base of AtreMorine and a natural source of L-DOPA, with an average concentration of 25 mg per gram of AtreMorine; it also contains a plethora of other bioactive substances as vegetal proteins, unsaturated fatty acids, minerals and vitamins, vegetal fibre, starch, vegetal pigments (carotenes) and vegetal sterols (phytosterols).



Download to find out more.

Close
Close
Close

Go Top